EGFR p.V774M/p. the S768I Compound Mutation in NSCLC Is a Good Prognostic Marker for IPHC‐ and Furmonertinib‐Based Treatment: A Case Report. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.